Abstract
Innate immune memory, also called “trained immunity,” is a functional state of myeloid cells enabling enhanced immune responses. This phenomenon is important for host defense, but also plays a role in various immune-mediated conditions. We show that exogenously administered sphingolipids and inhibition of sphingolipid metabolizing enzymes modulate trained immunity. In particular, we reveal that acid ceramidase, an enzyme that converts ceramide to sphingosine, is a potent regulator of trained immunity. We show that acid ceramidase regulates the transcription of histone-modifying enzymes, resulting in profound changes in histone 3 lysine 27 acetylation and histone 3 lysine 4 trimethylation. We confirm our findings by identifying single-nucleotide polymorphisms in the region of ASAH1, the gene encoding acid ceramidase, that are associated with the trained immunity cytokine response. Our findings reveal an immunomodulatory effect of sphingolipids and identify acid ceramidase as a relevant therapeutic target to modulate trained immunity responses in innate immune-driven disorders.
Original language | English |
---|---|
Article number | 113458 |
Number of pages | 25 |
Journal | Cell Reports |
Volume | 42 |
Issue number | 12 |
DOIs | |
Publication status | Published - 26 Dec 2023 |
Funding
This work was supported by the Hypatia grant by the Radboud university medical center and the Senior Kolff grant by the Dutch Kidney Foundation (to R.D.). C.Y. is supported by the Radboud university medical center PhD fellow program. M.G.N. L.A.B.J. and N.P.R. are supported by the Dutch Heart Foundation IN-CONTROL CVON grant (CVON2018-27). M.G.N. was supported by an ERC Advanced Grant (no. 833247) and a Spinoza Grant of the Netherlands Organization for Scientific Research. N.R. and R.D. designed the study. N.R. C.Y. G.P. I.J. M.J. M.M.T.v.L. J.v.H. V.M. A.A. R.v.d.M. Z.A.F. N.P.R. L.B.H. L.A.B.J. W.J.M.M. M.G.N. J.v.d.V. A.J.P.T. and R.D. designed, performed, and oversaw the experiments. G.P. A.A. W.J.M.M. and A.J.P.T. developed sphingolipid-loaded nanobiologics. N.R. C.Y. I.J. M.J. and R.D. performed in vitro trained immunity experiments. N.R. and J.H. performed Seahorse metabolic experiments. N.R. C.Y. and R.D. collected and prepared samples for lipidomic, transcriptomic, and epigenetic analysis. R.G.H.L. J.H.A.M. and M.V. performed RNA-seq and ChIP-seq data analysis. V.M. performed FTI-QTL analysis. The manuscript was written by N.R. and R.D. All authors contributed to writing the manuscript and approved the final draft. R.D. provided funding. The authors declare no competing interests. This work was supported by the Hypatia grant by the Radboud university medical center and the Senior Kolff grant by the Dutch Kidney Foundation (to R.D.). C.Y. is supported by the Radboud university medical center PhD fellow program. M.G.N., L.A.B.J., and N.P.R. are supported by the Dutch Heart Foundation IN-CONTROL CVON grant ( CVON2018-27 ). M.G.N. was supported by an ERC Advanced Grant (no. 833247 ) and a Spinoza Grant of the Netherlands Organization for Scientific Research .
Funders | Funder number |
---|---|
H2020 European Research Council | 833247 |
Hartstichting, Nederlandse | CVON2018-27 |
Nierstichting Nederland | |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek | |
Radboud University Medical Center |
Keywords
- acid ceramidase
- CP: Immunology
- epigenetics
- immune memory
- innate immunity
- lipid metabolism
- monocytes
- nanobiologics
- sphingolipids
- trained immunity